24 Nov

Change of Directors Interest Notice - Astles

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/ 0 9/01 Amended 01/01/11 Name of entity : A USTCO HEALTHCARE LIMITED ABN : 67 108 208 760 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Clayton Astles Date of last notice 2 4 November 20 20 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest D irect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Clayton Astles ATF the Clayton Astles RRSP account. Clayton Astles RRSP account held via HSBC Custody Nominees (Australia) Limited Date of change 2 4 November 202 1 Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 No. of securities held prior to change Direct: 640,994 Ordinary Shares 1,396,276 Unlisted options with an exercise price of $0.10 expiring on 18 March 2022 1,396,276 Unlisted options with an exercise price of $0.13 expiring on 17 March 2023 1,396,276 Unlisted options with an exercise price of $0.1 3 expiring on 1 2 February 202 4 1,3 50 , 000 Unlisted options with an exercise price of $0.13 expiring on 1 1 September 202 4 Indirect: 1,440,643 Ordinary Shares (held via HSBC Custody Nominees (Australia) Limited for the Clayton Astles RRSP account) 91,804 Ordinary S hares (held via Clayton Astles ATF the Clayton Astles RRSP account) Class Unlisted Options Number acquired D irect: 1,3 50 , 000 Unlisted options with an exercise price of $0. 215 expiring on 24 September 202 5 Number disposed Nil Value/Consideration Note: If consideration is non - cash, provide details and estimated valuation Nil Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 No. of securities held after change Direct: 640,994 Ordinary Shares 1,396,276 Unlisted options with an exercise price of $0.10 expiring on 18 March 2022 1,396,276 Unlisted options with an exercise price of $0.13 expiring on 17 March 2023 1,396,276 Unlisted options with an exercise price of $0.1 3 expiring on 1 2 February 202 4 1,3 50 , 000 Unlisted options with an exercise price of $0.13 expiring on 1 1 September 202 4 1,3 50 , 000 Unlisted options with an exercise price of $0. 215 expiring on 24 September 202 5 Indirect: 1, 440 , 643 Ordinary Shares (held via HSBC Custody Nominees (Australia) Lim ited for the Clayton Astles RRSP account ) 91,804 Ordinary Shares (held via Clayton Astles ATF the Clayton Astles RRSP account) Nature of change Example: on - market trade, off - market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy - back Issue of Options under the ESOP as approved by shareholders at the Annual General M eeting on 24 November 202 1 . Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 4 01/01/2011 Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non - cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? N /A If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A

More from Austco Healthcare Limited


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Austco Healthcare Limited (ASX:AHC) when you join Listcorp.